ProfileGDS4718 / 226999_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 48% 39% 45% 61% 30% 28% 32% 39% 51% 40% 51% 25% 43% 34% 35% 40% 41% 40% 55% 40% 44% 40% 44% 49% 30% 51% 62% 49% 37% 27% 24% 52% 36% 33% 41% 50% 41% 43% 25% 41% 42% 36% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3377247
GSM549102patient 115, normal, homogenized [OPG study]5.4410448
GSM549104patient 119, normal, homogenized [OPG study]4.9275139
GSM549108patient 138, normal, homogenized [OPG study]5.2991245
GSM549119patient 077, normal, homogenized [OPG study]6.1881461
GSM549133patient 032, cancer, homogenized [OPG study]4.4675430
GSM549139patient 042, cancer, homogenized [OPG study]4.4522728
GSM549099patient 107, normal, homogenized [OPG study]4.6459632
GSM549109patient 139, normal, homogenized [OPG study]4.9917239
GSM549110patient 046, normal, homogenized [OPG study]5.5620351
GSM549114patient 063, normal, homogenized [OPG study]4.9557340
GSM549122patient 082, normal, homogenized [OPG study]5.6068951
GSM549134patient 033, cancer, homogenized [OPG study]4.326625
GSM549136patient 036, cancer, homogenized [OPG study]5.1027143
GSM549140patient 044, cancer, homogenized [OPG study]4.6633134
GSM549111patient 047, normal, homogenized [OPG study]4.7314735
GSM549113patient 057, normal, homogenized [OPG study]4.9115340
GSM549132patient 031, cancer, homogenized [OPG study]5.0102241
GSM549137patient 038, cancer, homogenized [OPG study]4.9478840
GSM549142patient 047, cancer, homogenized [OPG study]5.9206655
GSM549100patient 110, normal, homogenized [OPG study]5.0043240
GSM549107patient 135, normal, homogenized [OPG study]5.1377944
GSM549115patient 068, normal, homogenized [OPG study]4.9249740
GSM549116patient 072, normal, homogenized [OPG study]5.1524944
GSM549120patient 078, normal, homogenized [OPG study]5.4590849
GSM549131patient 030, cancer, homogenized [OPG study]4.4688230
GSM549118patient 074, normal, homogenized [OPG study]5.5439251
GSM549129patient 027, cancer, homogenized [OPG study]6.2645162
GSM549123patient 088, normal, homogenized [OPG study]5.437249
GSM549124patient 006, cancer, homogenized [OPG study]4.8905437
GSM549126patient 015, cancer, homogenized [OPG study]4.4084427
GSM549128patient 025, cancer, homogenized [OPG study]4.2715324
GSM549103patient 117, normal, homogenized [OPG study]5.6944452
GSM549117patient 073, normal, homogenized [OPG study]4.7742736
GSM549138patient 041, cancer, homogenized [OPG study]4.641533
GSM549141patient 045, cancer, homogenized [OPG study]4.9621341
GSM549130patient 028, cancer, homogenized [OPG study]5.4878750
GSM549101patient 111, normal, homogenized [OPG study]5.081241
GSM549105patient 128, normal, homogenized [OPG study]5.1661743
GSM549106patient 134, normal, homogenized [OPG study]4.2874825
GSM549112patient 048, normal, homogenized [OPG study]5.0046241
GSM549125patient 011, cancer, homogenized [OPG study]5.0941342
GSM549127patient 024, cancer, homogenized [OPG study]4.8179436
GSM549135patient 035, cancer, homogenized [OPG study]4.2886525